Measures For Pharma GMP Compliance Rolled Out Across China
This article was originally published in PharmAsia News
Multiple regional Chinese regulators have announced measures to encourage drug makers to comply with the new GMPs through reasonable hardware expansion and the elimination of excessive capacity.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.